Detalhe da pesquisa
1.
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501.
J Gastroenterol Hepatol
; 36(11): 3041-3049, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152636
2.
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
Gastric Cancer
; 23(6): 1064-1074, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32372141
3.
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Cancer
; 123(6): 1061-1070, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926778
4.
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
Oncology
; 91(5): 283-288, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27577551
5.
Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
Dig Dis Sci
; 66(7): 2470-2471, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469810
6.
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
BMC Cancer
; 14: 357, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886605
7.
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).
Healthcare (Basel)
; 12(3)2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338289
8.
Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 30(1): 20-28, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799567
9.
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group.
Dig Liver Dis
; 56(1): 70-76, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481430
10.
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.
J Cell Mol Med
; 17(11): 1415-21, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24283947
11.
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.
Gastric Cancer
; 16(3): 411-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065042
12.
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
Support Care Cancer
; 21(5): 1313-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23196819
13.
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab.
Sci Rep
; 13(1): 21036, 2023 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030703
14.
Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy.
Cancers (Basel)
; 15(13)2023 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444451
15.
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease.
Biomed Pharmacother
; 157: 113901, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462311
16.
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Inflamm Bowel Dis
; 29(2): 217-221, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385102
17.
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
Inflamm Bowel Dis
; 29(9): 1380-1389, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222487
18.
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients.
J Cell Physiol
; 227(3): 927-33, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21503888
19.
High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease.
Oncologist
; 17(6): 823-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22584434
20.
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.
Oncology
; 82(2): 75-82, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22327844